Target Entity: Aditya Birla Health Insurance Co. Limited (ABHI)
Type of Deal: Rights issue investment in existing associate company
Stake/Capacity: No change in percentage shareholding - remains at 45.89%
Deal Value: ₹1,23,89,43,300 (Rupees One Hundred Twenty-Three Crore, Eighty-Nine Lakh, Forty-Three Thousand and Three Hundred Only)
Funding Source: Cash consideration
Financial Impact: The investment is specifically for meeting ABHI's solvency margin requirements. No additional financial impact on revenue, EBITDA, or margins is disclosed.
Timeline: The equity shares were allotted by ABHI on 21 July 2026 (completion date)
Strategic Rationale: The investment serves to support ABHI's regulatory capital requirements by meeting its solvency margin, ensuring compliance with insurance regulatory norms.
Approval Status: Transaction completed and shares allotted on 21 July 2026. The transaction is classified as a related party transaction but was executed at "arm's length."
Reference Regulation: SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30, and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026
